Font Size:
a
A
A
Keyword [transjugular]
Result: 61 - 80 | Page: 4 of 9
61.
The Application Of The Dual-source CT Angiography In The Preoperative Evaluation And Follow-up Of TIPS
62.
The Influnce Of Transjugular Intrahepatic Portosystemic Shunts (TIPS) And Modified Sugiura Operation (MSO) On Systemic Inflammatory Response And Intestinal Biological Barrier
63.
Clinical Application Of Viatorr Covered Stent In Transjugular Intrahepatic Portosystemic Shunt
64.
The Impact Of TIPS Joint PSE On Hemodynamic And Immune Function In Patients With Portal Hypertension And Hypersplenism
65.
EVL Versus TIPS In Cirrhosis Patients With Portal Vein Thrombosis And Esophageal Varices
66.
Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Therapy In The Secondary Prophylaxis Of Variceal Rebleeding In Hepatocirrhosis Patients:a Meta-analysis
67.
Current Diagnosis And Management Of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy
68.
Study Between The TIPS Stents Release Parameters And Shunt Dysfunction
69.
The Treatment Of TIPS For Cirrhotic Patients With RA:Risk Stratification And Survival Prediction
70.
Clinical Diagnosis And Treatment Of Hepatic Sinus Obstruction Syndrome
71.
Clinical Analysis Of Liver Cirrhosis With Portal Vein Thrombosis And Analysis Of Coagulation Related Indexes
72.
Transjugular Intrahepatic Portosystemic Shunt Plus Embolotherapy Prevents Rebleeding In Cirrhotic Patients With Cavernous Transformation Of The Portal Vein
73.
Transjugular Intrahepatic Portosystemic Shunt For The Prevention Of Recurrent Esophageal Variceal Bleeding In Patients With Cavernous Transformation Of Portal Vein
74.
Establishment And Validation Of Clinical Prediction Models In Patients With Early Hepatic Encephalopathy Undergoing Transjugular Intrahepatic Portosystemic Shunt
75.
Hemodynamic Characteristics And Individualized Interventional Treatment Of Gastric Fundal Varices
76.
Multimodal Magnetic Resonance Study Of Central Nervous System In Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic Shunt
77.
The Clinical Characteristics Of Cirrhosis With Portal Vein Thrombosis And The Clinical Application Of Transjugular Intrahepatic Portosystemic Shunt
78.
Clinical Outcomes Of Transcatheter Selective Superior Mesenteric Artery Urokinase Infusion Therapy Vs Transjugular Intrahepatic Portosystemic Shunt In Patients With Cirrhosis And Acute Portal Vein Thrombosis
79.
The Safety And Efficacy Of Tace Combined With Tips In Patients With Liver Cancer And Portal Hypertension
80.
Multivariate Analysis Of 331 Cases Of Cirrhosis And Portal Hypertension After TIPS Operation
<<First
<Prev
Next>
Last>>
Jump to